GBPJPY *For educational purpose only.
Back in May, a jury ruled in Harrow Health's favor in a lawsuit that Allergan filed against Harrow for intellectual property infringement. Allergan has been appealing the ruling, but today the two companies jointly filed an 8k form indicating that they had jointly dismissed all pending appeals and exchanged no money. In other words, Harrow got off scot-free and...
Upon dropping to 42 and approaching oversold territory, Micron has gotten some positive catalysts. A couple analyst agencies have upgraded Micron, bringing its Equity StarMine Summary Score to a surprising 8.9/10. Also, yesterday Micron filed a Form 4 indicating that one of the directors had purchased some shares. Unlikely though it seems to me given Micron's poor...
Assertio therapeutics is slated to get an FDA ruling on its new drug application for cosyntropin depot by October 19. If the FDA approves the drug, the stock could move up significantly. Assertio has an 8.9/10 Equity StarMine Summary Score and is rated extremely undervalued by S&P Capital IQ. Despite relatively good earnings last quarter, the stock price is down...
LXP blew away analyst expectations on its last earnings report, beating by 200%. It got a nice pop after earnings, then collapsed when it announced a $10 million share offering. It started to recover after it announced what it was doing with the money raised from investors: purchasing new properties to accelerate its growth. If LXP is as good a steward of the new...
I posted the other day about how the healthcare sector would be a good defensive play in October but for the political risk faced by health insurers and pharmaceutical companies. Well, here's a company with great financials and none (or at least less) of that political risk. SMED is a medical waste disposal company, and its services would still be in demand even...
UnitedHealth Group has had an incredibly strong showing this year, and right now it's priced pretty attractively at oversold level on the hourly chart. On its daily chart it's at RSI 38, nearing oversold (RSI 30) but not quite there yet. It also hasn't yet tested its August low of 220.78 or its one-year lows of 208.07 and 216.84. I suspect we'll get a bounce...
Funko had a substantial insider purchase on September 5, hired a new board member, and has had a lot of analyst upgrades recently. It now has a 9.1/10 Equity StarMine Summary Score. It's also rated highly undervalued by S&P Capital IQ. With several recent earnings beats, all indicators are good for this stock. Watch for a breakout above the ascending triangle.
Netease remains undervalued even after its recent surge. Its Equity StarMine rating is still sitting at 9.8/10, making it a high-rated stock. It currently looks to be to be cycling down to support around 262. That's a good buy level before a move up to previous highs around 289.65. Recognia's Elliott Wave price target is 299.62.
I've been watching UNH closely ever since its big guidance upgrade on the last earnings report. The stock chose that moment to start tanking, and it's been tanking ever since. Hopefully the market has now had enough of this down trend and is ready for the stock to recover. Zacks, one of the best-performing analytics firms, upgraded UNH today to a buy. It's got an...
Although Apple news claimed that the company “beat expectations,” the stock gapped up and quickly reversed, then moved down further. This is due to their Guidance for the next quarter. Many companies are able to beat the analysts’ estimates, but forecast lower for next earnings season.
Micron (MU) got an upgrade to "strong buy" over the weekend from Zack's, the best-performing analytics firm. It also got some huge options volume today, targeting $49 and $55 per share. That's probably on the strength of both the Zack's upgrade and the stock's ascending triangle break. The triangle break implies an upside of about $6 per share from the current level.
Zynga has a high-volume support node at 6.19 and could see a bounce from this level. I've got my stop loss at 6.15. ZNGA has a 7.7/10 Thomson Reuters Starmine Equity Summary Score, which is a really good rating.
Gain Capital Holdings has formed a mini double bottom and broken a couple trendlines. It should get up to at least the next trendline, though I have my doubts as to whether it can push through. The stock usually does well ahead of earnings, and right now it's being bolstered by an optimistic press release put out by the CEO promising good results from the next...
Orion Engineered Carbons has generally positive analyst ratings and positive earnings growth. Recognia's Elliott Wave analysis puts OEC in a bullish Wave 3 move with a price target of 22.71. OEC missed earnings estimates last quarter and took a pretty big hit. But with the materials sector looking so hot right now, I suspect OEC will indeed break out above the...
Skyline Holdings has formed a new parallel channel, with long-term trendline support at its channel bottom. It's currently oscillating toward channel bottom, but with great analyst ratings and a recent earnings beat, we should see another upward oscillation after that. Buy long near the trendline. As always, this is just an idea about how the market will move,...
indicators, analysts, etc are saying to long GBP. 5:1 ratio. small tp1. far tp2 & tp3. lets see what happen. cheers to many pips
On the daily chart, MACD and price have diverged nicely. On the weekly, stochastic is showing oversold. We are also at the .618 fib level from 52 week high. I'm going to call bottom between 52 and 54 before we start recovering. Also 35% retracement looks similar to February of last year. OIG subpoena is only related to one customer and will have a small effect....